En Es
Categories

Industry News

Global Infusion Pump Market to Surpass USD 850 Million by 2028

By HospiMedica International staff writers
21 Apr 2022

Image: Global infusion pump market is projected to register a CAGR of 4.0% during 2022-2028 (Photo courtesy of Pexels)

Infusion pumps are used to deliver medication in many cases, such as cancer and diabetic conditions, to keep drug levels in the bloodstream stable. These pumps have several advantages over manual fluid administration, including the ability to administer fluids in very small doses and at precise programmed rates. Chemotherapy must be delivered to cancer patients on a continuous basis, which can be accomplished with the help of a pump. Insulin pumps are becoming increasingly popular in the treatment of Type 1 diabetes. As a result, the global infusion pump market will be driven by rising incidence of chronic diseases, rapid growth of the geriatric population who require home care, rising demand for ambulatory infusion pumps, and growing volume of surgical procedures performed around the world.


These are the latest findings of Valuates Reports (Bangalore, India), a market research firm.


The global infusion pump market was valued at about USD 627 million in 2021 and is projected to grow at a CAGR of 4% during 2022-2028 to surpass USD 852 million by 2028. Growing demand for ambulatory infusion pumps in-home care settings, as well as an increase in chronic disease incidence, is expected to drive the growth of the infusion pump market. Infusion pumps for ambulatory use are designed to be portable or wearable. The high incidence and prevalence of chronic diseases, as well as rising healthcare expenditure, primarily on hospitalization, have increased the demand for home healthcare in recent years.


In addition, increasing research and development (R&D) activities to launch home infusion systems are expected to drive the growth of the infusion pump market. Rising costs of hospital-based infusion therapies have prompted an increase in R&D efforts to create home-based infusion products. For instance, the rising demand for long-term care, preferably in-home care settings, has been due to an increase in the patient population with diabetes, cancer, and neurological disorders. Furthermore, the growing geriatric population, which requires long-term care therapies, is driving new product development for home infusion therapies.


Furthermore, the use of robotics in surgical treatments and the introduction of technology in minimally invasive procedures are the keys to the future of surgical procedures, which will lead to an increase in sales of syringe and infusion pumps. This, in turn, is expected to drive the growth of the infusion pump market. Automated syringe pumps are commonly used in hospitals and clinics to improve the efficiency of drug infusion in the patient's body. Moreover, to increase their market share, the players in the global infusion pumps market are actively launching new products targeted at specific disease treatment procedures, and undertaking geographic expansions and collaborations.


Based on type, accessories/consumables is expected to be the most lucrative segment in the infusion pump market due to the frequent use and purchase of accessories/consumables for infusion therapy. Based on application, the oncology segment is expected to gain significant traction due to the rising prevalence of various cancers and the increasing number of new product launches in this area. Chemotherapy must be delivered to cancer patients on a continuous basis, which can be accomplished with the use of infusion pumps.


Geographically, North America is expected to be the world’s most lucrative market for infusion pumps due to the rapid adoption of technologically advanced products by patients and physicians, both for regular treatment of chronic disease conditions, in the region. In North America, several chronic diseases are becoming more prevalent, and the rapid adoption of home healthcare infusion pump therapies is also fueling the growth of the infusion pump market in the region.


Related Links:
Valuates Reports 



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

27 Jun 2022
Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries
Given the growing incidence of lifestyle diseases and demand for affordable healthcare, effective surgery using robotic devices can result in a decline in treatment costs and drive the growth of the global robot-assisted surgical devices (RASD) market.
Read More
24 Jun 2022
Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests
Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction of customary closing conditions.
Read More
23 Jun 2022
Hospital Microbiology Testing Market Driven by Increasing Prevalence of Chronic Diseases
Rising medical expenditure as well as the presence of well-established modern healthcare infrastructure in various developed as well as developing regions is fueling the growth of the global hospital microbiology testing market.
Read More
22 Jun 2022
Global Minimally Invasive Surgery (MIS) Market to Surpass USD 325 Billion by 2031
The global MIS market is projected to surpass USD 325 billion by 2031, driven by growing patient awareness of the advantages of MIS over open surgeries, continuous innovation in surgical robots, and constant advancements in other MIS-associated technologies during the 2022-2031 forecast period.
Read More
21 Jun 2022
Medix Biochemica Acquires IVD Raw Materials Producer Bioresource Technology
Medix Biochemica (Espoo, Finland) has acquired 100% of the shares of Bioresource Technology (BRT, Weston, FL, USA) to broaden its base matrix capabilities and further strengthen its local presence in the US market.
Read More
21 Jun 2022
Global Bedside Testing Market to Witness Promising Prospects in Critical Care
Point-of-care or point-of-use diagnostics, also known as bedside testing, has gained increased prominence in analytical testing over the past few years as it provides clinically relevant information without the need for a dedicated laboratory.
Read More
20 Jun 2022
Global Sepsis Diagnostics Market Driven by Rising Hospital-Acquired Illnesses
The global sepsis diagnostics market is expected to grow at a CAGR of 8.3% during the period 2022-2028 to reach almost USD 0.88 billion by 2028, driven by a rise in the number of hospital-acquired illnesses and the rapidly growing molecular diagnostics market, although the high cost of automated diagnostic instruments could hamper market growth.
Read More
14 Jun 2022
BD Partners with Mayo Clinic Platform for Access to World's Largest Collection of Clinical Data
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) has entered into a collaboration with Mayo Clinic Platform (Rochester, MN, USA) to access de-identified patient data from Mayo Clinic Platform_Discover.
Read More
14 Jun 2022
Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing
Quidel Corporation (San Diego, CA, USA) is joining forces with Global Lyme Alliance (Stamford, CT, USA) to heighten public awareness around Lyme disease during Lyme Disease Awareness Month (in May) and beyond.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions